Search results
BREATHE. EASY. Mobile Lung CT Coach To Host "Wipe Out Lung Cancer" At Chattanooga Red Wolves June 5
The Chattanoogan· 5 days agoCHI Memorial’s mobile lung CT coach will host a "Wipe Out Lung Cancer" event at the Chattanooga Red...
...PFL-002/VERT-002, a Potential Treatment for Patients with Solid Tumors, Including Non-Small Cell ...
KETK· 21 hours agoFood and Drug Administration ("FDA") to initiate a first-in-human (FIH) Phase I/II clinical trial with PFL-002/VERT-002 for solid tumors including non-small cell lung < ...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 23 hours agoThe clinical trial happened in China, meaning that a U.S.-based study will likely be required by the...
Phase III trial shows lorlatinib highly effective against ALK-positive non–small cell lung cancer
Medical Xpress· 1 day agoA large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating non–small cell lung
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab,...
Clearfield Progress· 4 days agoSugemalimab is expected to become the first anti-PD-L1 monoclonal antibody (mAb) in the world approved in Europe for both first-line squamous and non-squamous NSCLC, regardless of PD-L1 expression ...
Trial reveals benefits of 'stepped' palliative care for patients with advanced lung cancer
Medical Xpress· 3 days agoA new study led by investigators from Mass General Cancer Center reveals the effectiveness of more...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 4 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters· 5 days ago, opens new tab Trodelvy failed to improve survival for patients with advanced bladder cancer and...
New Pathways for Treating Never-Smoker Lung Cancer | Newswise
Newswise· 3 days agoKorean joint research team have elucidated the overexpression of estrogen signaling pathways in specific Korean never-smoking lung cancer cases using multi
Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus...
Benzinga via Yahoo Finance· 5 days agoThursday, Summit Therapeutics Inc (NASDAQ:SMMT) announced that Phase 3 HARMONi-2, or AK112-303, met...